RIPK1 and metabolic dysfunction-associated steatohepatitis: We demonstrate that UGDH suppresses hepatocyte apoptosis by inhibiting RIPK1 activation in both in vitro model of inflammation-induced hepatocellular death and in vivo model of NASH.